B+
Overall grade
B+
Financial quality
The sleeper story is that value creation initiatives are already driving gross margin expansion (86 bps sequentially, 25 bps YoY) through pricing power and product mix improvements, not just promised cost cuts. While the Street focuses on solid 6.3% sales growth, the real story is margin quality improvement happening now under new CEO Fred Lowery's 'sharper operational execution' approach. The binding constraint is digital equipment pricing pressure from new market entrants, which could spread to other categories if not contained. Most revealing quote: 'We are just beginning to unlock value from our value creation initiatives'-suggests more margin expansion ahead. My view changes if digital equipment ASP pressure accelerates beyond current 'essentially flat' levels or if medical respiratory headwinds persist beyond flu season normalization.
The 30-second version
- The sleeper story: Value creation initiatives are actually delivering gross margin expansion NOW, not just cost cuts later
- Strong Q1 sales growth (6.3%) masks a bifurcated business: dental momentum vs medical headwinds
- New CEO Fred Lowery is already changing the language around operational execution and performance culture
What changed this quarter
| Metric | Prior | This quarter |
|---|---|---|
| Global Sales | $3.4B (+7.7% YoY) | $3.4B (+6.3% YoY) |
| Non-GAAP EPS | $1.34 (+12.6% YoY) | $1.32 (+14.8% YoY) |
| Non-GAAP Operating Margin | 7.42% (flat YoY) | 7.53% (+28 bps YoY) |
| Adjusted EBITDA | $191M | $289M (+11.6% YoY) |
| US Dental Merchandise | 3.6% growth | 5.6% growth |
| US Medical Distribution | 4.9% growth | 1.3% growth |
| Global Specialty Products | 14.6% growth | 8.1% growth |
| Global Technology | 8.4% growth | 7.0% growth |
Accountability tracked
8 new promises made4 narrative shifts flagged6 prior promises graded
Inside the full report
The complete write-up covers the full promise ledger with kept/missed calls, disclosure-quality scoring, the metrics-vanished check, verification items, and the questions to ask next quarter.
Subscribe to Call Sheet Daily →